(Q63322570)

English

Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

short name

Tysabri Japan (English)

0 references

title

Multicenter Study of BG00002 in Japanese Subjects With RRMS, Consisting of a Multiple-Dose, Open-Label Evaluation of Its Safety, Tolerability, Pharmacokinetics and Pharmacodynamics (Part A) and a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Evaluation of Safety and Efficacy (Part B) (English)

0 references

0 references

0 references

0 references

November 2010

0 references